Monday November 30, 2020 from
Remote presentation
Presenter
Overview
Objectives
As a result of attending this session, participants will be able to:
- Recognize new developments in the field of cardiology
- Review the evidence for colchicine and omega-3s in CVD protection
- Identify situations in which NOAC use is appropriate in valvular a.fib
- Recognize the role of the placebo effect in patients complaining of statinside effects
- Recognize the equivalence of ticagrelor and clopidogrel in some clinical situations
Lectures by Christopher Labos
| When | Session | Talk Title | Room |
|---|---|---|---|
|
Mon-30 08:30 - 10:35 |
Plenary - 1 | Atrial fibrillation: What's new and what do you need to know | Remote presentation |
|
Mon-30 11:00 - 12:00 |
Important new cardio literature for the family doctor - Christopher Labos | Important new cardio literature for the family doctor | Remote presentation |